scholarly journals Hearing‐impaired population performance and the effect of hearing interventions on Montreal Cognitive Assessment ( MoCA ): Systematic review and meta‐analysis

2020 ◽  
Vol 35 (9) ◽  
pp. 962-971 ◽  
Author(s):  
Nattawan Utoomprurkporn ◽  
Katherine Woodall ◽  
Joshua Stott ◽  
Sergi G. Costafreda ◽  
Doris Eva Bamiou
Keyword(s):  
Systematic Review ◽  
Cognitive Assessment ◽  
Meta Analysis ◽  
Hearing Impaired ◽  
Montreal Cognitive Assessment ◽  
Population Performance

scholarly journals Accuracy of the short‐form Montreal Cognitive Assessment: Systematic review and validation

2019 ◽  
Vol 34 (10) ◽  
pp. 1515-1525 ◽  
Author(s):  
Jennifer A. McDicken ◽  
Emma Elliott ◽  
Gareth Blayney ◽  
Stephen Makin ◽  
Myzoon Ali ◽  
...  
Keyword(s):  
Systematic Review ◽  
Cognitive Assessment ◽  
Short Form ◽  
Montreal Cognitive Assessment

Systematic review and meta-analysis of the association of Autism Spectrum Disorder in visually or hearing impaired children

2017 ◽  
Vol 37 (2) ◽  
pp. 212-224 ◽  
Author(s):  
Belinda Do ◽  
Paige Lynch ◽  
Elena-Marie Macris ◽  
Brianna Smyth ◽  
Stephanie Stavrinakis ◽  
...  
Keyword(s):  
Systematic Review ◽  
Autism Spectrum Disorder ◽  
Meta Analysis ◽  
Autism Spectrum ◽  
Hearing Impaired ◽  
Spectrum Disorder ◽  
Impaired Children ◽  
Hearing Impaired Children

scholarly journals Montreal Cognitive Assessment for cognitive assessment in chronic kidney disease: a systematic review

2019 ◽  
Vol 41 (1) ◽  
pp. 112-123 ◽  
Author(s):  
Thaís Malucelli Amatneeks ◽  
Amer Cavalheiro Hamdan
Keyword(s):  
Systematic Review ◽  
Chronic Kidney Disease ◽  
Cognitive Impairment ◽  
Kidney Disease ◽  
Cognitive Assessment ◽  
Montreal Cognitive Assessment ◽  
Treatment Modalities ◽  
Cross Sectional ◽  
Application Profile ◽  
Made In

Abstract Introduction: There is evidence in the literature that cognitive impairment is more prevalent in individuals with chronic kidney disease (CKD) than in the general population. The Montreal Cognitive Assessment (MoCA) is an instrument with a good application profile for cognitive evaluation of patients with CKD-like impairments. The objective of this study is to perform a systematic review of MoCA use in the context of CKD. Method: The keywords "Montreal Cognitive Assessment", "Kidney Disease" and "Chronic Kidney Disease" were used to search the databases. The inclusion criteria were: a) empirical articles; b) approach to cognitive impairment in CKD; c) papers in Portuguese and English. Results: The studies were mostly cross-sectional, published in medical journals, with research carried out mostly in Europe. About 45% of the studies had samples of less than 150 participants and variations in the prevalence of cognitive impairment were found ranging from 28.9% to 74.6%. The cutoff point for the identification of the impairment presented variation between the studies. Discussion: The results' analysis demonstrates the need for more complete studies on MoCA scoring and adaptation in its different versions. We recommend to the health professionals who will use the results in the clinical setting that the interpretation of the results be made in the light of studies more related to the context lived by the patients. Conclusions: The instrument is efficient to be used in several stages and treatment modalities of the disease. We point to the need to adapt a cut-off point for the instrument in the different translations of the instrument.

Sign in / Sign up

Export Citation Format

Share Document